FOXO3 and metabolic dysfunction-associated steatotic liver disease: Nevertheless, the contribution of other miR-122-5p target genes to lipogenesis cannot be ruled out, and the gain- and loss-of-function analyses of miR-122-5p in vivo and in vitro suggested that miR-122-5p was able to promote NAFLD development through inhibiting FOXO3 function.